【jesus by greg olsen】IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
LOS ANGELES,jesus by greg olsen CA / ACCESSWIRE / April 2, 2020 /
The Schall Law Firm
, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Inovio Pharmaceuticals, Inc. ("Inovio" or "the Company") (NASDAQ:
INO
) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between February 14, 2020 and March 9, 2020, inclusive (the ''Class Period''), are encouraged to contact the firm before May 11, 2020.
If you are a shareholder who suffered a loss,
click here to participate
.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at
www.schallfirm.com
, or by email at
.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Inovio made misleading statements about its purported development of a vaccine for COVID-19 coronavirus. The materially misleading statements artificially inflated the Company's share price, resulting in investor losses. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Inovio, investors suffered damages,
Join the case
to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
www.schallfirm.com
SOURCE:
The Schall Law Firm
View source version on accesswire.com:
https://www.accesswire.com/583652/IMPORTANT-INVESTOR-NOTICE-The-Schall-Law-Firm-Announces-the-Filing-of-a-Class-Action-Lawsuit-Against-Inovio-Pharmaceuticals-Inc-and-Encourages-Investors-with-Losses-in-Excess-of-500000-to-Contact-the-Firm
View comments
本文地址：http://lout.fabrikasi.net/html/891d299106.html
版权声明
本文仅代表作者观点，不代表本站立场。
本文系作者授权发表，未经许可，不得转载。